BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 12614462)

  • 1. TyeA of Yersinia pseudotuberculosis is involved in regulation of Yop expression and is required for polarized translocation of Yop effectors.
    Sundberg L; Forsberg A
    Cell Microbiol; 2003 Mar; 5(3):187-202. PubMed ID: 12614462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TyeA, a protein involved in control of Yop release and in translocation of Yersinia Yop effectors.
    Iriarte M; Sory MP; Boland A; Boyd AP; Mills SD; Lambermont I; Cornelis GR
    EMBO J; 1998 Apr; 17(7):1907-18. PubMed ID: 9524114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetically engineered frameshifted YopN-TyeA chimeras influence type III secretion system function in Yersinia pseudotuberculosis.
    Amer AA; Costa TR; Farag SI; Avican U; Forsberg Å; Francis MS
    PLoS One; 2013; 8(10):e77767. PubMed ID: 24098594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translocation of YopE and YopN into eukaryotic cells by Yersinia pestis yopN, tyeA, sycN, yscB and lcrG deletion mutants measured using a phosphorylatable peptide tag and phosphospecific antibodies.
    Day JB; Ferracci F; Plano GV
    Mol Microbiol; 2003 Feb; 47(3):807-23. PubMed ID: 12535078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YscB of Yersinia pestis functions as a specific chaperone for YopN.
    Jackson MW; Day JB; Plano GV
    J Bacteriol; 1998 Sep; 180(18):4912-21. PubMed ID: 9733695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yersinia enterocolitica TyeA, an intracellular regulator of the type III machinery, is required for specific targeting of YopE, YopH, YopM, and YopN into the cytosol of eukaryotic cells.
    Cheng LW; Schneewind O
    J Bacteriol; 2000 Jun; 182(11):3183-90. PubMed ID: 10809698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YopN and TyeA Hydrophobic Contacts Required for Regulating Ysc-Yop Type III Secretion Activity by Yersinia pseudotuberculosis.
    Amer AA; Gurung JM; Costa TR; Ruuth K; Zavialov AV; Forsberg Å; Francis MS
    Front Cell Infect Microbiol; 2016; 6():66. PubMed ID: 27446813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YopN Is Required for Efficient Effector Translocation and Virulence in Yersinia pseudotuberculosis.
    Bamyaci S; Ekestubbe S; Nordfelth R; Erttmann SF; Edgren T; Forsberg Å
    Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29760214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of Yersinia Yop-effector delivery by translocated YopE.
    Aili M; Isaksson EL; Carlsson SE; Wolf-Watz H; Rosqvist R; Francis MS
    Int J Med Microbiol; 2008 Apr; 298(3-4):183-92. PubMed ID: 17597003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of chaperone-dependent Yop secretion/translocation and effector function using a mini-virulence plasmid of Yersinia enterocolitica.
    Trülzsch K; Roggenkamp A; Aepfelbacher M; Wilharm G; Ruckdeschel K; Heesemann J
    Int J Med Microbiol; 2003 Jun; 293(2-3):167-77. PubMed ID: 12868653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uncovering an Important Role for YopJ in the Inhibition of Caspase-1 in Activated Macrophages and Promoting Yersinia pseudotuberculosis Virulence.
    Schoberle TJ; Chung LK; McPhee JB; Bogin B; Bliska JB
    Infect Immun; 2016 Apr; 84(4):1062-1072. PubMed ID: 26810037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SycN/YscB chaperone-binding domain of YopN is required for the calcium-dependent regulation of Yop secretion by Yersinia pestis.
    Joseph SS; Plano GV
    Front Cell Infect Microbiol; 2013; 3():1. PubMed ID: 23355975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YopD of Yersinia pseudotuberculosis is translocated into the cytosol of HeLa epithelial cells: evidence of a structural domain necessary for translocation.
    Francis MS; Wolf-Watz H
    Mol Microbiol; 1998 Aug; 29(3):799-813. PubMed ID: 9723919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The V antigen of Yersinia pestis regulates Yop vectorial targeting as well as Yop secretion through effects on YopB and LcrG.
    Nilles ML; Fields KA; Straley SC
    J Bacteriol; 1998 Jul; 180(13):3410-20. PubMed ID: 9642196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The type III secretion chaperone LcrH co-operates with YopD to establish a negative, regulatory loop for control of Yop synthesis in Yersinia pseudotuberculosis.
    Francis MS; Lloyd SA; Wolf-Watz H
    Mol Microbiol; 2001 Nov; 42(4):1075-93. PubMed ID: 11737648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yersinia enterocolitica can deliver Yop proteins into a wide range of cell types: development of a delivery system for heterologous proteins.
    Boyd AP; Grosdent N; Tötemeyer S; Geuijen C; Bleves S; Iriarte M; Lambermont I; Octave JN; Cornelis GR
    Eur J Cell Biol; 2000 Oct; 79(10):659-71. PubMed ID: 11089914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proinflammatory signalling stimulated by the type III translocation factor YopB is counteracted by multiple effectors in epithelial cells infected with Yersinia pseudotuberculosis.
    Viboud GI; So SS; Ryndak MB; Bliska JB
    Mol Microbiol; 2003 Mar; 47(5):1305-15. PubMed ID: 12603736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection and characterization of Yersinia pestis YopN mutants that constitutively block Yop secretion.
    Ferracci F; Schubot FD; Waugh DS; Plano GV
    Mol Microbiol; 2005 Aug; 57(4):970-87. PubMed ID: 16091038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competition between the Yops of Yersinia enterocolitica for delivery into eukaryotic cells: role of the SycE chaperone binding domain of YopE.
    Boyd AP; Lambermont I; Cornelis GR
    J Bacteriol; 2000 Sep; 182(17):4811-21. PubMed ID: 10940022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The YopB protein of Yersinia pseudotuberculosis is essential for the translocation of Yop effector proteins across the target cell plasma membrane and displays a contact-dependent membrane disrupting activity.
    Håkansson S; Schesser K; Persson C; Galyov EE; Rosqvist R; Homblé F; Wolf-Watz H
    EMBO J; 1996 Nov; 15(21):5812-23. PubMed ID: 8918459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.